NCT06090487Completed
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function and Performance in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting Post-operatively in the Intensive Care Unit
Source: ClinicalTrials.gov · Last updated 5 Sept 2024
Brief summary (registry, in English)
The aim of this study is to assess whether sacubitril-valsartan is more effective than dapagliflozin in improving function, myocardial performance in patients undergoing CABG operation or not
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 9 Oct 2023
- Start date
- 1 Feb 2024
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Ain Shams University
- Diseases
- Heart failure
- NCT number
- NCT06090487
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Feb 2024 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
Other illness
- Any allergy to the used drugs
Other
- ASA 4 or more
- Bypass time of more than 1 hour
- Coronary grafts of more than 2
Who the study is looking for
- Age between 50 to 70 years old
- DM type 2
- ASA 3
- Only 2 coronary grafts
- Elective surgery
- Bypass time less than 1 hour
- Senior staff cardiothoracic
Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.